Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | GAA | P10253 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | XDH | P47989 | 1/20 | 0.56 |
| ▸ | GFER | P55789 | 1/20 | 0.56 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.56 |
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL475746 | 0.95 | CA1 (0.61) | CA1CA2CA12CA7CA9 | |
| SCHEMBL16533898 | 0.88 | CA1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL11264625 | 0.87 | CA1 (0.53) | CA1CA2CA12CA7CA9 | |
| SCHEMBL988746 | 0.87 | CA1 (0.53) | CA1CA2CA12CA7CA9 | |
| SCHEMBL55814 | 0.87 | CA1 (0.73) | CA1CA2CA12CA7CA9 | |
| SCHEMBL56890 | 0.87 | KDM4E (0.55) | CA1CA2CA12CA7CA9 | |
| Methyl 3,5-Dimethoxybenzoate SCHEMBL7801783 | 0.87 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL27994343 | 0.87 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL1708877 | 0.87 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL17462467 | 0.86 | CA1 (0.52) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119638556-A | Stilbene derivative, preparation method thereof and application thereof in preparing medicines for treating psoriasis or ulcerative colitis | 华中科技大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119504367-A | Preparation method of benvimod | 承德医学院 | 2025-02-25 | — | — | CN | claimed |
| CN-118420440-A | Preparation method of trans-resveratrol | 河北科技大学 | 2024-08-02 | — | — | CN | claimed |
| CN-117285413-A | Synthesis method of terbutaline key intermediate 3, 5-dihydroxyacetophenone | 重庆恩联生物科技有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-117105768-A | Preparation method of 4-isopropyl 3, 5-dimethoxy benzoic acid | 承德医学院 | 2023-11-24 | — | — | CN | claimed |
| CN-114487237-B | Detection method of 3, 5-dimethoxy methyl benzoate | 中山奕安泰医药科技有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116354810-A | Radioisotope carbon-14 multi-site marked emodin and preparation method thereof | 浙江爱索拓标记医药科技有限公司 | 2023-06-30 | — | — | CN | claimed |
| US-11440920-B2 | Chemical method of producing SMTP groups or SMTP-7 and intermediates used in the method | SHOWA UNIVERSITY (JP) | 2022-09-13 | — | — | US | claimed |
| CN-114487237-A | Detection method of 3, 5-dimethoxybenzoic acid methyl ester | 中山奕安泰医药科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113387800-A | Preparation method of 3, 5-dimethoxybenzoic acid methyl ester | 浙江理工大学 | 2021-09-14 | — | — | CN | claimed |
| CN-109232302-B | Azobenzene carboxylic acid derivative with visible light controlled cis-trans isomerism characteristic and application and synthetic method thereof | 厦门大学 | 2020-10-09 | — | — | CN | claimed |
| US-20200140450-A1 | CHEMICAL METHOD OF PRODUCING SMTP GROUPS OR SMTP-7 AND INTERMEDIATES USED IN THE METHOD | SHOWA UNIVERSITY (JP) | 2020-05-07 | — | — | US | claimed |
| CN-122029153-A | Aromatic hydrocarbon receptor modulator compound, and preparation method and application thereof | 德明药泰生物技术（深圳）有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250382250-A1 | STILBENE DERIVATIVE AS AHR AGONIST AND USE THEREOF | NANJING GRITPHARMACO LTD (CN) | 2025-12-18 | — | — | US | disclosed |
| EP-3745105-B1 | TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME | HITACHI LTD (JP) | 2025-08-27 | — | — | EP | disclosed |
| WO-2025099634-A1 | PROCESS FOR PREPARING THE POLYMORPHIC FORM III OF TAPINAROF | PROCOS S.P.A. (IT) | 2025-05-15 | — | — | WO | disclosed |
| US-4393070-A | HYPOTENSIVE, VASODILATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-07-12 | — | — | US | disclosed |
| US-4342875-A | STABILIZERS FOR OLEFIN POLYMERS | CINCINNATI-MILACRON, INC. (US) | 1982-08-03 | — | — | US | disclosed |
| US-4307103-A | TREATMENT OF HYPERTENSION AND CARDIOVASCULAR DISEASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-12-22 | — | — | US | disclosed |
| US-4180669-A | ANTISECRETORY AGENTS | ABBOTT LABORATORIES (US) | 1979-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382250-A1 | STILBENE DERIVATIVE AS AHR AGONIST AND USE THEREOF | AHR, ARNT, RORB | CA1 4508/4885CA2 3602/4885CA12 4513/4885 |
| US-20200140450-A1 | CHEMICAL METHOD OF PRODUCING SMTP GROUPS OR SMTP-7 AND INTERMEDIATES USED IN THE METHOD | TST, SMS, TMSB4X | CA1 3648/4885CA2 3841/4885CA12 4493/4885 |
| US-11440920-B2 | Chemical method of producing SMTP groups or SMTP-7 and intermediates used in the method | SMS, TST, TES | CA1 4122/4885CA2 3981/4885CA12 4670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.